BIO P178 Bug Bite/Plant Irritation Study – Multiple Groups


BIO P178 Bug Bite/Plant Irritation Study – Multiple Groups
Posted  July 9, 2024

START DATE07/12/2024
QUALIFICATIONSMales and Females Ages: 18-75
FITZPATRICK TYPES1 2 3 4 
TIME REQUIREMENT1 visit - 6.5 hours sequestered
COMPENSATION$200

Prescreening is required in the BIO Department. Come in anytime to prescreen.

This is a one (1) day sequestered study. Subjects will report to ECRL with a product free body and either a bug bite or plant irritation. They will consent and then have various grading, chromameter readings, and images will be taken throughout the course of the study duration.

Conflicting studies: Any full body study

Inclusion criteria:

  • Subject is female or male between 18 and 75 years of age;
  • Subject is Fitzpatrick Skin Type I-IV
  • Subject has moderate itch from a plant related irritation or insect bite at Baseline (50 subjects with plant related irritation and 50 subjects with insect bite)
  • Subject presents with at least mild redness from a plant related irritation or insect bite at Baseline.
  • Subject agrees to be sequestered at ECRL for approximately 6.5 hours;
  • Subject agrees not to wash/wet or apply any product to the selected test site until the completion of the study;
  • Subject agrees to refrain from scratching/touching the test site for the duration of the study;
  • Subject agrees to wear clothing that allows for easy access to the selected test site;
  • Subject agrees not to introduce any new cosmetic or toiletry products during the study;
  • Subject is dependable and able to follow directions as outlined in the protocol
  • Subject is willing to participate in all study evaluations
  • Subject is in generally good health and has a current Panelist Profile Form on file at CRL;

Exclusion criteria:

  • Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
  • Subject has applied any topical anti-itch/bug bite relief product to the test site since the irritation appeared;
  • Subject is currently using any systemic or topical corticosteroids, anti-inflammatory drugs, antihistamines, or
    retinoids or any medication that, in the opinion of the Principal Investigator, may influence the outcome of the study
  • Subject exhibits irritation that presents coupled with oozing/secretions/bleeding
  • Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs;
  • Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would preclude application of the test material and/or could influence the outcome of the study;
  • Subject is on a study utilizing the same test site selected;
  • Subject exhibits irritation, excessive hair, tattoos, sunburn, rashes, scratches, burn marks, scarring, etc. on the test sites, which might interfere with evaluation of test results;
  • Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study;
  • Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind;
  • Subject has diabetes.

GROUP 1
V1: FRI, 7/12 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 2
V1: WED, 7/17 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 3
V1: FRI, 7/19 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 4
V1: MON, 7/22 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 5
V1: FRI, 7/26 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 6
V1: MON, 7/29 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

GROUP 7
V1: WED, 7/31 – 6.5 HR SEQUESTER

HOURS: 8:00am TO 10:30am

Speak to a Recruiter for more information.

 

 

 




Sign up today!